<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1749</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2024-32-s1-562-566</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>TO ASSESS THE EFFECTIVENESS OF TREATMENT METHODS FOR PATIENTS OF DIFFERENT AGE GROUPS WITH BASAL CELL CANCER OF THE SKIN OF THE NOSE AND EARS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Volgin</surname><given-names>V. N.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kagoiancz</surname><given-names>R. V.</given-names></name><email></email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sadykova</surname><given-names>R. N.</given-names></name><email></email><xref ref-type="aff" rid="aff-4"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mingazova</surname><given-names>E. N.</given-names></name><email></email><xref ref-type="aff" rid="aff-5"/><xref ref-type="aff" rid="aff-2"/><xref ref-type="aff" rid="aff-6"/><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff id="aff-1">Main Military Clinical Hospital named after Academician N. N. Burdenko, 105094, Moscow, Russia</aff><aff id="aff-2"></aff><aff id="aff-3">Clinical hospital «RZD-Medicine» of the city of Rostov-on-Don, 344011, Rostov-on-Don, Russia</aff><aff id="aff-4">N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia</aff><aff id="aff-5">Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation — A. I. Burnazyan Federal Medical Biophysical Center of the Federal Medical Biological Agency of Russia, 123098, Moscow, Russia</aff><aff id="aff-6">Tatarstan Аcademy of Sciences, 420111, Kazan, Russia</aff><aff id="aff-7">Kazan State Medical University, 420012, Kazan, Russia</aff><pub-date date-type="epub" iso-8601-date="2024-07-09" publication-format="electronic"><day>09</day><month>07</month><year>2024</year></pub-date><volume>32</volume><issue>7</issue><fpage>562</fpage><lpage>566</lpage><history><pub-date date-type="received" iso-8601-date="2025-07-02"><day>02</day><month>07</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 1970,</copyright-statement><copyright-year>1970</copyright-year></permissions><abstract>The relevance of the problems of diagnosis and treatment of skin cancer is currently determined not only by the high incidence rate, but by the existing difficulties in differential diagnosis and treatment with traditional methods. For localizations of basal cell skin cancer (BCSC) that are “inconvenient” for treatment, such as the external auditory canal, auricle, and wing of the nose, treatment is associated with certain difficulties and the possible appearance of a cosmetic defect, therefore, when choosing a treatment method, the anatomical features of these organs are taken into account. It has been determined that the effectiveness of treatment for primary BCSC of the nose and auricles is higher than recurrent one, and among the various treatment methods, the most effective and radical is the surgical method. The immediate results of treatment of BCSC in the form of PR by surgical method were 86.7%, which is statistically significant compared with other types of treatment (p lt; 0.05). Long-term treatment results with the surgical method are also higher (77%) compared to other methods, which is also statistically significant (p lt; 0.05).</abstract><kwd-group xml:lang="en"><kwd>skin cancer</kwd><kwd>basal cell carcinoma</kwd><kwd>carcinoma</kwd><kwd>population</kwd><kwd>treatment methods</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак кожи</kwd><kwd>базальноклеточный рак</kwd><kwd>карцинома</kwd><kwd>базалиома</kwd><kwd>население</kwd><kwd>методы лечения</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Каприн А. Д., Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2018 году. М.; 2019. 236 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.; 2018. 250 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Каприн А. Д., Старинский В. В., Состояние онкологической помощи населению России в 2021 году. М.; 2022. 239 с.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М.; 2019. 250 с.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Roewert-Huber J., Lange-Asschenfeldt B., Stockfleth E., Kerl H. Epidemiology and aetiology of basal cell carcinoma // Br. J. Dermatol. 2007. Vol. 157, Suppl 2. P. 47–51. DOI: 10.1111/j.1365-2133.2007.08273.x</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Tanese K. Diagnosis and management of basal cell carcinoma // Curr. Treat. Options Oncol. 2019. Vol. 20, N 2. P. 13. DOI: 10.1007/s11864-019-0610-0</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Хабриев Р. У., Садыкова Р. Н., Мингазова Э. Н., Беспятых Ю. А. Молекулярно-генетические аспекты базальноклеточной карциномы с позиций здоровьесбережения населения // Проблемы социальной гигиены, здравоохранения и истории медицины. 2023. Т. 31, №5. С. 946–950. DOI: 10.32687/0869-866X-2023-31-5-946-950</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Клинические рекомендации: базальноклеточный рак кожи. М.; 2020. 91 с.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Khan N. H., Mir M., Qian L. et al. Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures // J. Adv. Res. 2021. Vol. 36. P. 223–247. DOI: 10.1016/j.jare.2021.06.014</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Lopez A. T., Carvajal R. D., Geskin L. Secondary prevention strategies for nonmelanoma skin cancer // Oncology. 2018. Vol. 32, N 4. P. 195–200.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Thomson J., Hogan S., Leonardi-Bee J. et al. Interventions for basal cell carcinoma of the skin // Cochrane Database Syst. Rev. 2020. Vol. 11, N 11. P. CD003412. DOI: 10.1002/14651858</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Хабриев Р. У., Садыкова Р. Н., Мингазова Э. Н., Беспятых Ю. А. Социально-генетические аспекты высокой распространенности и профилактики базальноклеточной карциномы // Проблемы социальной гигиены, здравоохранения и истории медицины. 2023. Т. 31, №4. С. 527–534. DOI: 10.32687/0869-866X-2023-31-4-527-534</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Dika E., Scarfì F., Ferracin M. et al. Basal cell carcinoma: a comprehensive review // Int. J. Mol. Sci. 2020. Vol. 21, N 15. P. 5572. DOI: 10.3390/ijms21155572</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Heath M. S., Bar A. Basal cell carcinoma // Dermatol. Clin. 2023. Vol. 41, N 1. P. 13–21. DOI: 10.1016/j.det.2022.07.005</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Basset-Seguin N., Herms F. Update in the management of basal cell carcinoma // Acta Derm. Venereol. 2020. Vol. 100, N 11. P. adv00140. DOI: 10.2340/00015555-3495</mixed-citation></ref></ref-list></back></article>
